LAURETA SEY: Open Payments
NPI 1639812332 · OWINGS MILLS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,249 in 58 payments from 16 companies in 2025. Trend: 2023 $1,263 · 2024 $2,246 · 2025 $1,249
Food & beverage: $1,249
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $241 |
| AstraZeneca Pharmaceuticals LP | 8 | $179 |
| Lilly USA, LLC | 7 | $121 |
| PFIZER INC. | 5 | $90 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $87 |
| GlaxoSmithKline, LLC. | 4 | $71 |
| Exact Sciences Corporation | 3 | $70 |
| Kowa Pharmaceuticals America, Inc. | 4 | $67 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $67 |
| Astellas Pharma US Inc | 3 | $54 |
Products named: FARXIGA, Rybelsus, Ozempic, MOUNJARO, JARDIANCE, Kerendia, ZORYVE, Veozah.
Industry payments across MD — which companies pay providers there.
